Family Medicine · Anchorage, AK
NPI
1033598875
Since 2015
Specialty
Family Medicine
Code 207Q00000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1200 W Northern Lights Blvd Ste A
Anchorage, AK, 99503
Phone (907) 212-3420
Groups this clinician bills Medicare through
Medicare paid, 2024
$257K
5,382 services
Medicare patients, 2024
681
Average age 73
Drug cost, 2024
$1.1M
9,061 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Taro Satake was code J0897 (injection, denosumab, 1 mg), 1,560 times for 22 patients. In total Taro Satake billed 5,382 services in 45 codes, and Medicare paid $257K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,560 | 22 | $20.36 | $32K |
| 99214 Office E&M - Established | Office | 902 | 493 | $106.06 | $96K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 785 | 458 | $16.07 | $13K |
| 99213 Office E&M - Established | Office | 333 | 246 | $68.88 | $23K |
| 83036 Blood Count | Office | 241 | 169 | $9.48 | $2,284 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 126 | 126 | $161.74 | $20K |
| 99215 Office E&M - Established | Office | 119 | 97 | $161.51 | $19K |
| 99211 Office E&M - Established | Office | 110 | 70 | $20.38 | $2,242 |
| G0008 Administration of influenza virus vaccine | Office | 92 | 88 | $40.57 | $3,732 |
| 90653 Vaccine Product | Office | 67 | 67 | $81.82 | $5,482 |
| 96372 Injection Administration | Office | 67 | 32 | $12.06 | $808 |
| 98926 Spinal Manipulation | Office | 64 | 26 | $41.98 | $2,687 |
| 98925 Spinal Manipulation | Office | 63 | 43 | $28.08 | $1,769 |
| 90480 Vaccine Administration | Office | 44 | 43 | $54.10 | $2,380 |
| 91322 Vaccine Product | Office | 41 | 41 | $112.06 | $4,594 |
By year: 2022 $157K for 2,226 services; 2023 $206K for 3,331 services; 2024 $257K for 5,382 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 241 | 169 | $9.48 | $2,284 |
Medicare prescription drug claims, 2024
In 2024, the drug Taro Satake prescribed most often to Medicare patients was Atorvastatin Calcium, with 768 prescriptions and refills. In total Taro Satake wrote 9,061 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 768 | 1,669 | 179 | $10K |
| Losartan Potassium Generic | 369 | 889 | 100 | $4,401 |
| Lisinopril Generic | 285 | 647 | 69 | $2,461 |
| Amlodipine Besylate Generic | 284 | 696 | 75 | $2,422 |
| Metformin Hcl Generic | 278 | 606 | 65 | $2,727 |
| Levothyroxine Sodium Generic | 268 | 632 | 61 | $3,231 |
| Tamsulosin Hcl Generic | 223 | 578 | 70 | $4,809 |
| Gabapentin Generic | 203 | 385 | 41 | $3,761 |
| Rosuvastatin Calcium Generic | 189 | 477 | 55 | $4,155 |
| Donepezil Hcl Generic | 182 | 292 | 27 | $4,264 |
| Pantoprazole Sodium Generic | 179 | 296 | 37 | $2,027 |
| Omeprazole Generic | 173 | 349 | 43 | $2,286 |
| Escitalopram Oxalate Generic | 165 | 343 | 36 | $2,702 |
| Eliquis Apixaban | 151 | 264 | 31 | $137K |
| Allopurinol Generic | 145 | 313 | 35 | $1,742 |
Brand drugs: 1,314 claims; generic drugs: 7,683 claims; opioid claims: 82.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Taro Satake were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.